title: Hyperuricaemia and the metabolic syndrome in type 2 DM.
abstract: BACKGROUND
  Elevated serum uric acid levels (SUA) have been associated with an increased risk of cardiovascular diseases and the metabolic syndrome (MetS) and are often reported to be higher in females than in males. The aim of this report is to determine the prevalence and clinical correlates of hyperuricaemia and also to evaluate associations with the MetS in people with type 2 diabetes mellitus (DM).
  
  
  METHODS
  This was a cross-sectional study conducted in people with type 2 DM in Lagos, Nigeria. Hyperuricaemia was defined by cut-off values of > 7 mg/dl for men and > 6 mg/dl for women. The diagnosis of MetS was made using the new definition by the American Heart Association and other related bodies. Clinical and biochemical parameters were compared between subjects with hyperuricaemia and normouricaemia. Statistical analysis included usage of Student's t test, Pearson correlation coefficients, multivariate regression analysis and chi square.
  
  
  RESULTS
  601 patients with type 2 DM aged between 34-91 years were recruited for the study. The prevalence rates of hyperuricaemia and the MetS were 25% and 60% respectively. The frequency of occurrence of hyperuricaemia was comparable in both genders (59% vs 41%, p = 0.3). Although, the prevalence of the MetS in subjects with hyperuricaemia and normouricaemia was comparable (61 vs 56%, p = 0.1), a higher proportion of hyperuricaemic subjects had 3 or more components of the Mets compared with normouricaemic subjects. Possible predictors of hyperuricaemia include central obesity, smoking and elevated serum triglycerides (TG). SUA levels were found to be positively and significantly associated with serum TG (r = 0.2, p = 0.0001) and total cholesterol (r = 13, p = 0.001).
  
  
  CONCLUSIONS
  The prevalence of hyperuricaemia in subjects with type 2 DM is comparable in both genders and possible predictors of hyperuricaemia are potentially modifiable. SUA is positively and significantly associated with serum TG and total cholesterol.
authors.affiliation: Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria. oogbera@yahoo.co.uk
authors.forename: Anthonia O
authors.initials: AO
authors.lastname: Ogbera
authors.forename: Alfred O
authors.initials: AO
authors.lastname: Azenabor
references.citation: J Hum Hypertens. 2009 Feb;23(2):113-21
references.pmid: 18719615
references.citation: J Gerontol A Biol Sci Med Sci. 2002 Oct;57(10):M660-4
references.pmid: 12242321
references.citation: Chest. 2007 May;131(5):1473-8
references.pmid: 17494796
references.citation: JAMA. 1993 Jul 21;270(3):354-9
references.pmid: 8315780
references.citation: Clin Chem. 1972 Jun;18(6):499-502
references.pmid: 4337382
references.citation: Clin Chem. 1973 May;19(5):476-82
references.pmid: 4703655
references.citation: Asia Pac J Clin Nutr. 2009;18(1):81-7
references.pmid: 19329400
references.citation: Stroke. 1998 Mar;29(3):635-9
references.pmid: 9506605
references.citation: Intern Emerg Med. 2008 Dec;3(4):313-8
references.pmid: 18320146
references.citation: Am J Physiol Renal Physiol. 2006 Mar;290(3):F625-31
references.pmid: 16234313
references.citation: Metabolism. 2008 Jun;57(6):845-52
references.pmid: 18502269
references.citation: Metabolism. 2007 Jun;56(6):751-6
references.pmid: 17512306
references.citation: Arch Intern Med. 1973 Sep;132(3):401-10
references.pmid: 4783021
references.citation: Ethn Dis. 2007 Autumn;17(4):676-81
references.pmid: 18072378
references.citation: Atherosclerosis. 2008 Apr;197(2):638-45
references.pmid: 17945241
references.citation: Acta Med Scand. 1988;224(6):549-55
references.pmid: 3207067
references.citation: BMC Public Health. 2004 Mar 25;4:9
references.pmid: 15043756
references.citation: Int J Obes Relat Metab Disord. 1996 Nov;20(11):975-80
references.pmid: 8923153
references.citation: J Zhejiang Univ Sci B. 2007 Aug;8(8):593-8
references.pmid: 17657863
references.citation: Int J Epidemiol. 1999 Oct;28(5):888-93
references.pmid: 10597987
references.citation: J Assoc Physicians India. 2006 Oct;54:797-810
references.pmid: 17214277
references.citation: Curr Opin Lipidol. 2007 Jun;18(3):263-70
references.pmid: 17495599
references.citation: Circulation. 2009 Oct 20;120(16):1640-5
references.pmid: 19805654
references.citation: Blood Press. 2009;18(5):268-72
references.pmid: 19919398
references.citation: Diabetes Care. 2008 Feb;31(2):361-2
references.pmid: 17977935
references.citation: N Engl J Med. 1966 Sep 1;275(9):457-64
references.pmid: 5917940
references.citation: Clin Chem. 1977 May;23(5):882-4
references.pmid: 192488
references.citation: J Hum Hypertens. 1994 Sep;8(9):677-81
references.pmid: 7807497
references.citation: Am J Epidemiol. 1988 Feb;127(2):321-36
references.pmid: 3337086
references.citation: J Biol Chem. 1952 Mar;195(1):357-66
references.pmid: 14938387
references.citation: Nihon Rinsho. 1996 Dec;54(12):3369-73
references.pmid: 8976122
references.citation: Am J Clin Nutr. 1967 Jul;20(7):777-82
references.pmid: 6036267
references.citation: Metabolism. 1998 Apr;47(4):435-8
references.pmid: 9550542